From our Annual Public Meeting to topic-specific convenings, the Reagan-Udall Foundation for the FDA brings stakeholders together on matters critical to regulatory science and practice. These events, often hosted at the request of FDA leadership, provide space for expert analysis and candid discussion on FDA’s priority issues. See below for upcoming events.

Past Events

Remarks by Dr. Hahn to the Global Coalition for Regulatory Science Research

I’m delighted to be with you today for this important meeting of the Global Coalition for Regulatory Science Research.  I only wish that we could be together in person.

Expanded access eRequest app allows physicians to submit EA requests online - The Cancer Letter

The Reagan-Udall Foundation for the FDA, with input from experts at FDA, has introduced an Expanded Access eRequest app to streamline expanded access for individual patients in non-emergency settings.

Ask the Accelerators: Dr. William Morice of Mayo Clinic Laboratories on RWE and COVID-19 diagnostics - Aetion

Dr. William Morice of Mayo Clinic Laboratories shares insights on real-world evidence (RWE) and its role in advancing COVID-19 diagnostics in this Aetion 'Ask the Accelerators' feature.

It Just Got Easier for Physicians to Help Their Patients Gain Access to Investigational Treatments

When a patient is in need of an important medicine, paperwork and forms are the last thing their physician wants to deal with. In some cases, it’s necessary, but the U.S.

New Expanded Access eRequest App Allows Physicians to Submit EA Requests Online

Submitting expanded access requests to FDA just got easier for physicians.

Covid-19 Molecular Diagnostic Testing — Lessons Learned - The New England Journal of Medicine

On February 4, 2020, the U.S.

Ask the Accelerators: Dr. Nirosha Lederer on COVID-19’s implications for the future of RWE, and what we’ve learned so far - Aetion

Dr. Nirosha Lederer discusses COVID-19’s impact on the future of real-world evidence (RWE), key learnings, and evolving regulatory perspectives in this Aetion 'Ask the Accelerators' interview.

UPDATED: Aetion pushes Series B to $82M as pandemic puts real-world evidence under the spotlight - Endpoints News

Former FDA chief Scott Gottlieb’s favorite real-world evidence platform is getting a new stream of cash, as it nears what will likely be the biggest test of the young company so far.

FDA In Brief: Findings from Real-World Data Study Reveal Higher Risk of Hospitalization and Death Among Cancer Patients with COVID-19, Underscore Health Disparities

The following quote is attributed to Harpreet Singh, M.D., Associate Director, Cancer in Older Adults and Special Populations, FDA’s Oncology Center of Excellence; and Director, Division of Oncology 2, FDA’s Center for Dru

FDA’s Ongoing Work to Support and Advance COVID-19 Diagnostic Test Accuracy and Availability

The U. S.